InterMune (NASDAQ: ITMN) jumped 42 cents at $11.80 Thursday, a correction following the prior days’ steep decline. The Brisbane, Ca.-based biotech company saw its shares plunged 75% Wednesday after the U.S. Food and Drug Administration (FDA) refused to approve its experimental drug to treat a rare lung disorder.
Sign Up for FREE
The #1 Authority on Penny Stocks
for OVER 7 YEARS RUNNING
Featured Contributor
GWBU is the next Awesome Penny Stock Alert
Ok this will be short and sweet with many more details to come, but everyone was asking me “What is the next AwesomePennyStock Alert?” Today we have our answer in ...
We Realized 130% On LQMT, Look At The Money Subscribers Made
On Wednesday April 18th, 2012 at 9:30 a.m. EST my chat room moderators noticed an article on Liquidmetal Technologies (OTCBB:LQMT) that we knew would drive the share price significantly higher. ...
Hot Stock Ideas
